Historical review from 2026-11-16. Current price and availability are unconfirmed; check the original marketplace.
Omnira is a profitable mobile wellness app generating $19.9K/mo with exceptional 65% margins and a 2.6x annual profit multiple—well below market for established recurring-revenue businesses. The 22-month operating history, verified financials (100 data quality score), and proprietary 8D Audio Creator differentiate the product, though buyer should confirm customer acquisition cost, retention cohorts, and the sustainability of current growth before committing.
The 8D Audio Creator and production-ready iOS implementation represent meaningful software assets, but the primary value lies in verified recurring revenue ($20K/mo), proven margins (65%), and established customer base. A solo founder could recreate a basic audio wellness app (meditation sounds, simple focus timer) in 16 weeks using AI-assisted development, Supabase or Firebase for backend, and third-party audio libraries, at a cost of $8K–$18K (AI subscription, hosting, initial asset creation). However, rebuilding the 8D Audio processing pipeline and acquiring 20K+ MRR in users organically would require 6–12 months of market validation and customer acquisition spending. The business justifies acquisition primarily on traction and durability (70% weighting), with software reproducibility a secondary factor (10% weighting). Verified financials and profitability lower execution risk significantly.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Omnira is a profitable iOS wellness app for sleep, focus, and relaxation. Its standout 8D Audio Creator transforms music into an immersive listening experience. Users can also create personalized medi
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.